Ignite Creation Date:
2024-05-06 @ 1:40 AM
Last Modification Date:
2024-10-26 @ 11:07 AM
Study NCT ID:
NCT01867996
Status:
COMPLETED
Last Update Posted:
2017-05-11
First Post:
2013-05-30
Brief Title:
A Study to Evaluate the Pharmacokinetics Safety and Tolerability of Retosiban GSK221149 When Dosed With Efavirenz EFZ
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Obstetric Labour Premature |
Keywords:
| Name | View |
|---|---|
| Retosiban Efavirenz Induction | View |